N
Neomed Institute
Response to the changing pharma r&d business model
About Neomed Institute
adMare BioInnovations operates as a pan-Canadian enterprise focused on transforming the country's life sciences sector by building new companies, developing talent, and fostering robust ecosystems. The organization was formed in 2019 through the merger of two prominent Canadian innovation entities: Vancouver's Centre for Drug Research and Development (CDRD), established in 2007, and Montreal's NEOMED Institute, which was created in 2012. This strategic union created a national powerhouse, led by President and CEO Gordon C. McCauley, an experienced life sciences executive who previously headed CDRD.
The business model is centered on bridging the gap between academic research and commercial viability. adMare sources promising therapeutic research from academic and biotech partners and applies its scientific, commercial, and capital resources to create and scale up new life sciences companies. The organization provides a comprehensive suite of support, including specialized R&D infrastructure in its Montreal and Vancouver Innovation Centres, seed capital, and hands-on expertise in drug development, intellectual property, and business strategy. Revenue is generated through returns on these investments, which are then reinvested back into the Canadian life sciences industry to ensure long-term sustainability.
adMare's core services are structured around three pillars: building companies, building ecosystems, and building talent. It creates new ventures from scratch, invests in existing early-stage companies to help them grow, and runs the adMare Tx National Accelerator to support therapeutic ventures. The Innovation Centres in Montreal and Vancouver provide state-of-the-art lab space and equipment for dozens of resident biotech companies and research organizations. To cultivate human capital, the adMare Academy offers several programs, including an Executive Institute, to train the next generation of scientific and business leaders for Canada's life sciences industry.
Source: Dealroom company dataNews
Open roles
Neomed Institute in the Montreal ecosystem
The Neomed Institute office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Government of Canada
Series B and later1 investor entered at this stage
AdMare BioInnovations
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Neomed Institute on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Neomed Institute on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

